Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatChemical/toxinWistarMalen = Preliminary study 8 per group; formal study taurocholate an…Intravenous via femoral vein10 mg/kg, selected from a preliminary dose-ranging study of…30 minutes before induction of pancreatitis (pretreatment)
Model: Acute necrotizing pancreatitis induced by retrograde biliary-pancreatic duct infusion of 5% sodium taurocholate, with secondary hepatic injury
Zerumbone pretreatment significantly reduced serum amylase, sPLA2, ALT and AST and improved pancreatic and hepatic histopathology, inhibited NF-kappaB and downregulated ICAM-1 and IL-1beta mRNA. In the preliminary study neither 5 nor 40 mg/kg improved sPLA2 and ALT, and 10 mg/kg was the minimum eff…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.